We took something great and made it better!

Since its introduction in 1993 as one of the first benchtop automated random access immunoassay systems, DPC's IMMULITE^® has developed a worldwide reputation as the most flexible, reliable, and robust system on the market. This is evidenced by the nearly 6,000 placements in hospitals, reference laboratories and physician's office laboratories worldwide.

Now DPC is proud to introduce the newest member of the evolving IMMULITE family of immunoassay systems—the IMMULITE^® 1000. DPC has taken something great and made it even better, while still maintaining the IMMULITE's strongest features, including its extensive menu, ease of use, reliability, robust hardware and excellent assay performance.

Several new features have been incorporated into the IMMULITE 1000 design to bring today's laboratories more of what they have come to expect from an automated immunoassay system. These features include

	Consolidated footprint
	State-of-the-art Microsoft® Windows® 2000 software
	On-board generic reagents
	On-board dilutions
	Positive sample identification
	Enhanced Turbo applications
	Remote Diagnostics.

Consolidated footprint
The IMMULITE 1000 footprint has been consolidated by integrating the computer, keyboard and monitor within the system. The floating arm for the monitor, keyboard and trackball can be adjusted to accommodate nearly all operators. This integration of the computer components takes up less bench space, allowing for easy installation even in laboratories with space constraints. The IMMULITE 1000 can be network-linked for printing, enabling the printer to be moved away from the system for optimal space management. In addition, the generic reagent containers such as those for water and probe wash have been built into the system to further reduce the system footprint.

Intuitive software
The IMMULITE 1000's state-of-the-art user software is designed to include all of the best features of the IMMULITE^® 2000, while retaining all of the highly functional, user-friendly features of the original IMMULITE. Operators enjoy simple and quick system navigation providing "anywhere to anywhere" access at the touch of an icon. The IMMULITE 1000 continually monitors reagents, consumables and system waste, indicating system status with clear visual and audible guides. The software automatically updates reagent and consumable inventory status without user intervention, providing a real-time record for easy system management. The software also features an excellent and comprehensive yet flexible solution for QC management. The OnLine Reports tracking and trending (Levey-Jennings plot) allow for user-definable Westgard rules, providing the ability to create customized patient reports. In addition, the IMMULITE 1000 software is capable of multilingual support for six languages.

On-board dilutions
The IMMULITE 1000 has automatic on-board dilutions for many prediluted assays, simplifying the dilution process. Diluents reside within a barcoded reagent wedge on the reagent carousel and have been consolidated into Universal Diluents for multiple tests such as ToRCH IgG/IgM to minimize space usage on the reagent carousel. The process is simple for the operator to perform, and it removes many manual dilution steps.

Positive sample identification
The IMMULITE 1000 has the ability to utilize positive secondary sample identification. A designated sample tube can be barcoded and scanned via the peripheral hand-held scanner. A modified sample cup holder is then scanned to identify the location of the sample on the system. The sample tube is placed on board, followed by the tests to be run. After completion of the analysis, the sample tube can be removed and used for further analysis or capped for storage as required. These tubes can also be used for undiluted control material or for the prediluted assays such SHBG, Anti-TPO Ab and Anti-TG Ab.

Enhanced Turbo applications
Further enhancing the flexibility and utility of the system is the IMMULITE 1000 Turbo mode, which produces results in as little as 15 minutes for assays such as the cardiac biomarkers CK-MB, Myoglobin, Troponin I and D-Dimer.* Additional Turbo assays include STAT Intact PTH and HCG. Switching between normal operation and Turbo mode is quick and easy. By merely exiting the normal operation software and touching the Turbo icon, the operator is ready to begin testing, once samples and Turbo reagents have been loaded. The IMMULITE 1000 offers the flexibility of a STAT system and the advantages of a primary testing analyzer—all in one reliable system.

Menu, menu, menu
The IMMULITE 1000 offers essentially the same extensive menu of nearly 100 tests and the same quality results as the IMMULITE. The IMMULITE/ IMMULITE 1000 test menu will continue to expand, and several new assays will be ready for market introduction in the coming months.

Remote Diagnostics
World-class technical service and customer support are the standard at DPC. Continuing in this tradition is the IMMULITE 1000 and its Remote Diagnostics capability. Using a modem link, the IMMULITE 1000 can be accessed remotely by DPC's Technical Service personnel to diagnose and resolve system issues quickly and effectively with minimal intervention by the operator. Modem access is available only with the user's permission, preserving laboratory control of the system. This level of service continues to raise the bar for delivering "best of breed" service to our customers.

Across the board, beta-site evaluators have responded favorably to the IMMULITE 1000. Several users stated that the software was so easy to use, almost no training was necessary. Others found that the on-board dilutions were simple and straightforward. Built on the solid foundation of the original IMMULITE, the IMMULITE 1000 provides the ease of use, reliability, and flexible platform necessary to make consolidation of immunoassay testing an effortless decision for today's clinical laboratory. For additional information on the IMMULITE 1000 or for an on-site demonstration, please contact us at 800.986.1001 and ask for Customer Service.

*Under development